8G48

FphE, Staphylococcus aureus fluorophosphonate-binding serine hydrolases E, unbound, dimer crystal form 3

Summary for 8G48

• Entry DOI: 10.2210/pdb8g48/pdb
• Descriptor: Fluorophosphonate-binding serine hydrolase E (2 entities in total)
• Functional Keywords: fphe, staphylococcus aureus, s. aureus, fluorophosphonate-binding, serine hydrolases, lipase, hydrolase
• Biological source: Staphylococcus aureus subsp. aureus USA300
• Total number of polymer chains: 1
• Total formula weight: 31275.10

Authors

Fellner, M. (deposition date: 2023-02-08, release date: 2024-02-21, Last modification date: 2026-04-01)

Primary citation

Jo, J.,Upadhyay, T.,You, X.,Bennett, J.M.,Lee, H.,Bogyo, M.,Fellner, M.
Unique structural and ligand-binding properties of the Staphylococcus aureus serine hydrolase FphE.
Proc.Natl.Acad.Sci.USA, 123:e2532683123-e2532683123, 2026

PubMed Abstract: is a human pathogen capable of forming biofilms that complicate treatment and facilitate chronic infections. A family of serine hydrolases are important regulators of virulence and biofilm formation. Among these, FphE is highly specific to and therefore a viable target for both imaging and therapy. Here, we present bioinformatic and structural evidence that FphE may be involved in aromatic compound metabolism. In addition, 12 distinct crystal forms reveal that FphE exists as a highly unusual but stable and flexible, cross-subunit homodimer, unique to the large alpha/beta hydrolase superfamily. Substrate engagement favors retention of the dimeric state, which is a more catalytically active form of the enzyme, and small-angle X-ray scattering confirms that the dimeric architecture occurs in solution. High-resolution cocrystal structures of FphE covalently bound to two chemically distinct ligands reveal different modes of active site engagement, supporting an atypical structural plasticity of the dimer interface. Together, these findings establish FphE as a structurally unique alpha/beta hydrolase and provide a foundation for structure-guided development of -specific inhibitors and imaging probes.

PubMed: 41875159
DOI: 10.1073/pnas.2532683123

Experimental method

X-RAY DIFFRACTION (1.95 Å)